Cluster lot quality assurance sampling: effect of increasing the number of clusters on classification precision and operational feasibility

J Infect Dis. 2014 Nov 1;210 Suppl 1(Suppl 1):S341-6. doi: 10.1093/infdis/jiu162.

Abstract

Background: To assess the quality of supplementary immunization activities (SIAs), the Global Polio Eradication Initiative (GPEI) has used cluster lot quality assurance sampling (C-LQAS) methods since 2009. However, since the inception of C-LQAS, questions have been raised about the optimal balance between operational feasibility and precision of classification of lots to identify areas with low SIA quality that require corrective programmatic action.

Methods: To determine if an increased precision in classification would result in differential programmatic decision making, we conducted a pilot evaluation in 4 local government areas (LGAs) in Nigeria with an expanded LQAS sample size of 16 clusters (instead of the standard 6 clusters) of 10 subjects each.

Results: The results showed greater heterogeneity between clusters than the assumed standard deviation of 10%, ranging from 12% to 23%. Comparing the distribution of 4-outcome classifications obtained from all possible combinations of 6-cluster subsamples to the observed classification of the 16-cluster sample, we obtained an exact match in classification in 56% to 85% of instances.

Conclusions: We concluded that the 6-cluster C-LQAS provides acceptable classification precision for programmatic action. Considering the greater resources required to implement an expanded C-LQAS, the improvement in precision was deemed insufficient to warrant the effort.

Keywords: Nigeria; cluster lot quality assurance sampling; polio eradication; supplementary immunization activities; survey methods.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Child, Preschool
  • Female
  • Health Services Research*
  • Humans
  • Immunization, Secondary / methods*
  • Infant
  • Infant, Newborn
  • Lot Quality Assurance Sampling / methods*
  • Male
  • Nigeria
  • Poliomyelitis / prevention & control*
  • Poliovirus Vaccines / administration & dosage*
  • Poliovirus Vaccines / immunology*

Substances

  • Poliovirus Vaccines